Press Releases | Swedish Health Press

Explore more publications!

Press Releases

Feb. 13, 2026

Expanding Role of Wound Care Devices Market with USD 3.64 Billion in 2026 in Modern Medicine

GlobeNewswire, Inc.

Feb. 12, 2026

Building a Healthier Tomorrow: Women’s Digital Health Grows at 20.54% CAGR by 2034

GlobeNewswire, Inc.

Feb. 9, 2026

Healthcare Security Systems Market to Reach USD 35.27 Billion by 2034 at 10.63% CAGR

GlobeNewswire, Inc.

Feb. 10, 2026

Wearable Medical Devices Market Projected to Reach USD 523.58 Billion, Growing at a 25.57% CAGR by 2035

GlobeNewswire, Inc.

Hans Schambye Appointed as Chief Executive Officer of BOOST Pharma

Feb. 10, 2026

Hans Schambye Appointed as Chief Executive Officer of BOOST Pharma

GlobeNewswire, Inc.

Feb. 9, 2026

Europe In-Vitro Diagnostics Market Poised for Strong Growth Driven by Rising Cancer and Chronic Disease Cases (2025–2034)

GlobeNewswire, Inc.

Hospital HVAC Systems Market Projected to Grow from USD 11.03 Billion in 2024 to USD 22.19 Billion by 2034, with a CAGR of 7.24%

Feb. 5, 2026

Hospital HVAC Systems Market Projected to Grow from USD 11.03 Billion in 2024 to USD 22.19 Billion by 2034, with a CAGR of 7.24%

GlobeNewswire, Inc.

Feb. 3, 2026

Medical Equipment Maintenance Market Size and Growth Analysis (2025-2034)

GlobeNewswire, Inc.

Feb. 6, 2026

Press conference on support to Ukraine in the areas of health and medical care and social policy

Government Offices of Sweden

Owner: Swedish Government

Government Offices of Sweden

Gov't Institution

Owned By	Swedish Government
Year Founded	Indeterminate
Website	https://www.government.se/
Domain Registration Year	Indeterminate
Access Type	open
Publication Location	Sweden, Stockholm
Owner Country	Sweden

We welcome your feedback!
If you have comments or corrections, let us know.

Feb. 5, 2026

Chiesi Global Rare Diseases Reinforces Long-Term Commitment to the Rare Disease Community with Multiple Abstract Presentations at the 22nd Annual WORLDSymposium™

GlobeNewswire, Inc.

Feb. 5, 2026

Chiesi Global Rare Diseases Reinforces Long-Term Commitment to the Rare Disease Community with Multiple Abstract Presentations at the 22nd Annual WORLDSymposium™

GlobeNewswire, Inc.

Feb. 5, 2026

Alvotech Announces Positive Top-Line Results from Pivotal Pharmacokinetic Study for Proposed Biosimilar to Entyvio®

GlobeNewswire, Inc.

Syncfusion® Sponsors .NET MAUI Day London and Attends Swetugg Stockholm 2026

Feb. 5, 2026

Syncfusion® Sponsors .NET MAUI Day London and Attends Swetugg Stockholm 2026

GlobeNewswire, Inc.

Food Processing Innovation: Perten Opens Process NIR Center of Excellence in Stockholm

Feb. 5, 2026

Food Processing Innovation: Perten Opens Process NIR Center of Excellence in Stockholm

EIN Presswire

Faith Feeds Food Pantry Partners with Endeavor Health to Transport More Fresh, Healthy Perishables to Its Mobile Pantry

Feb. 4, 2026

Faith Feeds Food Pantry Partners with Endeavor Health to Transport More Fresh, Healthy Perishables to Its Mobile Pantry

EIN Presswire

Jan. 29, 2026

Healthcare Mobility Solutions Market Accelerates at 20.44% CAGR, Targeting USD 1.05 Trillion by 2034

GlobeNewswire, Inc.

Premier At-Home Waxing Solution Tress Wellness Launches in Meijer

Feb. 2, 2026

Premier At-Home Waxing Solution Tress Wellness Launches in Meijer

EIN Presswire

Jan. 30, 2026

Chiesi Global Rare Diseases and Protalix BioTherapeutics Receive Positive CHMP Opinion for an Additional Dosing Regimen of Every Four Weeks for Elfabrio® (pegunigalsidase alfa) in the EU

GlobeNewswire, Inc.

Jan. 30, 2026

Chiesi Global Rare Diseases and Protalix BioTherapeutics Receive Positive CHMP Opinion for an Additional Dosing Regimen of 2mg/kg Body Weight Every-Four-Weeks for Elfabrio® (pegunigalsidase alfa) ▼ in the EU

GlobeNewswire, Inc.

Ardena completes divestment of its Södertälje drug substance site in Sweden to Nanologica

Jan. 29, 2026

Ardena completes divestment of its Södertälje drug substance site in Sweden to Nanologica

GlobeNewswire, Inc.